$116.79
3.312.92%
At close: -
$116.88
0.090.08%
After Hours: 7:59 PM EDT
Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.
The most recent guidance for Abbott Laboratories (ABT) was reported on October 16, 2024 for Q4 2024. The company provided earnings per share guidance in the range of $1.31 to $1.37, compared to the estimated EPS of $1.34. Additionally, Abbott Laboratories forecasted revenue between $0.00B and $0.00B for the quarter.
Browse guidance and forecast on all stocks.